Prostate Cancer Clinical Trial
Official title:
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
The primary objective of this study is to evaluate the performance of HR-TRUS in detection of prostate cancer lesions relative to whole mount section after radical prostatectomy as the reference.
The primary objective of this study is to evaluate the performance of HR-TRUS in detection of prostate cancer lesions relative to whole mount section after radical prostatectomy as the reference. The analysis will include the detection of all prostate cancer lesions as well as the detection of significant prostate cancer lesions. With this approach it is possible to calculate the sensitivity, specificity, negative predictive value, positive predictive value and overall accuracy of the correct detection of prostate cancer in the prostate. These results are of importance when the ExactVu ultrasound scanner is to be used later for prostate cancer diagnosis using targeted biopsies. ;
| NCT number | NCT03679819 |
| Study type | Observational |
| Source | Institut Paoli-Calmettes |
| Contact | Dominique Genre, MD |
| Phone | (00) 4 91 22 37 78 |
| [email protected] | |
| Status | Recruiting |
| Phase | |
| Start date | September 5, 2019 |
| Completion date | December 31, 2021 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04081636 -
Prostate Biopsy: Efficacy and Complications
|
N/A | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Recruiting |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Active, not recruiting |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A | |
| Active, not recruiting |
NCT00499421 -
Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
|
||
| Recruiting |
NCT03668652 -
Focal Prostate Ablation Versus Radical Prostatectomy
|
N/A | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A | |
| Recruiting |
NCT04219059 -
MR Radiomic Features in Prostate Cancer
|
||
| Recruiting |
NCT04249154 -
Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT03700099 -
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide
|
Phase 2 | |
| Recruiting |
NCT04383210 -
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
|
Phase 2 | |
| Terminated |
NCT00953576 -
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04586335 -
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
|
Phase 1 | |
| Recruiting |
NCT03568188 -
Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer
|
Phase 2 |